Michelle Murphy, PhD

Medical Science Liaison
Impel Pharmaceuticals
Seattle, Washington

Presentation(s):

• Poster Number-4 - Improvements in Productivity and Disability With INP104 as Assessed by the Migraine Disability Assessment Scale (MIDAS): Results From the Phase 3 STOP 301 Study

  Poster Abstracts